Do statins reduce hepatitis C RNA titers during routine clinical use?-Reference-Cited by-同舟云学术

Do statins reduce hepatitis C RNA titers during routine clinical use?

Published:2009 Issue:40 Volume:15 Page:5020
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:en
Short-container-title:WJG

Author:

Forde Kimberly A,Law Connie,O’Flynn Rose,Kaplan David E

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference24 articles.

1. McHutchison JG, Dev AT. Future trends in managing hepatitis C. Gastroenterol Clin North Am 2004;33:S51-S61.

2. Alter MJ. Epidemiology of hepatitis C. Hepatology 1997;26:62S-65S.

3. Dominitz JA, Boyko EJ, Koepsell TD, Heagerty PJ, Maynard C, Sporleder JL, Stenhouse A, Kling MA, Hrushesky W, Zeilman C. Elevated prevalence of hepatitis C infection in users of United States veterans medical centers. Hepatology 2005;41:88-96.

4. Sloan KL, Straits-Tröster KA, Dominitz JA, Kivlahan DR. Hepatitis C tested prevalence and comorbidities among veterans in the US Northwest. J Clin Gastroenterol 2004;38:279-284.

5. Cheung RC. Epidemiology of hepatitis C virus infection in American veterans. Am J Gastroenterol 2000;95:740-747.

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic and pharmacological perturbation of hepatitis-C virus entry;Current Opinion in Virology;2023-10

2. Atorvastatin favorably modulates a clinical hepatocellular carcinoma risk gene signature;Hepatology Communications;2022-06-16

3. PHARMACOLOGICAL PROTECTION OF VASCULAR ENDOTHELIUM IN ACUTE COVID-19;J PHYSIOL PHARMACOL;2022

4. Anti-flavivirus Properties of Lipid-Lowering Drugs;Frontiers in Physiology;2021-10-07

5. Interdependent Impact of Lipoprotein Receptors and Lipid-Lowering Drugs on HCV Infectivity;Cells;2021-06-29